Pink Fund Announces Gissoo DeCotiis As New Board Member
Gissoo DeCotiis, head of Global Advocacy & Strategic Relations & Oncology Medical Affairs for Daiichi Sankyo, has been added to Pink Fund's Board of Directors.
DeCotiis has more than 30 years of experience in various industries with a Master's Degree in Business (Finance). She joined Daiichi Sankyo in 2018 as Sr. Director of Global Advocacy in Global Medical Affairs and has been involved with all early and late-stage assets for the organization.
"After losing my beloved brother to cancer at 58, my life's work became centered on understanding and addressing the needs of those living with the disease by listening to the experts – the patients themselves," DeCotiis said. "Pink Fund plays a crucial role in this mission by helping patients and families tackle the financial struggles that so often accompany a cancer diagnosis. As part of Pink Fund, I can honor my brother's legacy by ensuring financial hurdles do not impede the vital care and support patients and their families desperately need."
DeCotiis' passion for advocacy and dedication to patients will add invaluable insight to the board.
"I am delighted with the rest of the Board of Directors of Pink Fund to welcome Gissoo DeCotiis to our board,"
ABOUT PINK FUND
Pink Fund is a 501c3 non-profit organization that provides education and financial support to help meet basic needs, decrease stress levels, and allow breast cancer patients in active treatment to focus on healing while improving survivorship outcomes. Founded in 2006, Pink Fund has provided more than
View original content to download multimedia:https://www.prnewswire.com/news-releases/pink-fund-announces-gissoo-decotiis-as-new-board-member-302162381.html
SOURCE Pink Fund
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Apex Institute Reveals What Hiring Managers Actually Want in Cloud and AI Infrastructure Roles
- XRP Price Prediction Turns Explosive at $1.48 While Pepeto Wallets Rush the Presale Before Listing
- Hyperliquid Price Prediction: HYPE Eyes $100 as This AI Presale at $0.02761 Offers the Earlier 10x Setup
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share